Xylem Inc.
107.64USD
-1.1700 (-1.08%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,336 | 2,125 | 2,397 | 2,268 | 2,301 | 2,069 | 2,256 | 2,104 |
| Cost of Revenue | 1,373 | 1,322 | 1,465 | 1,385 | 1,409 | 1,301 | 1,399 | 1,320 |
| Gross Profit | 963 | 803 | 932 | 883 | 892 | 768 | 857 | 784 |
| Operating Income | 390 | 244 | 353 | 334 | 305 | 231 | 267 | 280 |
| Net Income | 263 | 193 | 335 | 227 | 226 | 169 | 326 | 217 |
| EPS (Diluted) | $1.11 | $0.79 | $1.37 | $0.93 | $0.93 | $0.69 | $1.33 | $0.89 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)